SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/74FAA2ECAF816B369E3F7C54BADEB24409360E7DD887FFB504B7A654C75D4E93867DC3FF56F4735023CA68092F7E4CFD>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/74FAA2ECAF816B369E3F7C54BADEB24409360E7DD887FFB504B7A654C75D4E93867DC3FF56F4735023CA68092F7E4CFD
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/74FAA2ECAF816B369E3F7C54BADEB24409360E7DD887FFB504B7A654C75D4E93867DC3FF56F4735023CA68092F7E4CFD
http://www.w3.org/2000/01/rdf-schema#comment
"Identify CH5424802 as a potent selective and orally available ALK inhibitor with a unique chemical scaffold showing preferential antitumor activity against cancers with gene alterations of ALK."
xsd:string
http://purl.uniprot.org/uniprot/#_C91B11AE93C71143A5792C04A542182A74127A7848A3B0AE080980F3F553D2BCB93E36404CFCD86F8C0F1B1E16915DB3
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/74FAA2ECAF816B369E3F7C54BADEB24409360E7DD887FFB504B7A654C75D4E93867DC3FF56F4735023CA68092F7E4CFD
http://purl.uniprot.org/uniprot/B6D4Y6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/74FAA2ECAF816B369E3F7C54BADEB24409360E7DD887FFB504B7A654C75D4E93867DC3FF56F4735023CA68092F7E4CFD
http://purl.uniprot.org/uniprot/#_B6D4Y6-mappedCitation-21575866
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/74FAA2ECAF816B369E3F7C54BADEB24409360E7DD887FFB504B7A654C75D4E93867DC3FF56F4735023CA68092F7E4CFD